Jump to the main content block

National Taipei University of Technology

Home Taipei Tech 中文

kv en

Rapid Commercialization
Formulation optimization
Mass Production(Scale-Up)

We are actively seeking collaboration opportunities with international partners

High-Value
Biomaterials

Research and Commercialization Center

researchArea en

Key research areas

HBRCC (MT3+) is dedicated to bridging the gap between research and production in the medical device industry, specializing in optimizing biomaterial formulas, mass production, and rapid commercialization, while also providing multidisciplinary talent training and industry-academia collaborations to enhance the competitiveness of Taiwanese biomedical industries.

Biomaterials Testing Platform

Pre-clinical Testing Platform

Medical device commercialization

Research results

Events

2023-12-08 2023/11 Taiwan Healthcare+ Expo
2023-12-08 2023/11/30 MT3+ at 2023 Taiwan Healthcare+ Expo
2023-09-02 2023/09/01 ISOMRM Satellite Conference (MT3+ Kick Off Meeting)
2023-08-20 2023/09/01 ISOMRM Satellite Conference

Featured box

ISOMRM Satellite Conference (NTUT)

Visit official website to see more information

Medical device commercialization

please click here to see accomplishment for medical device commercialization

Propaganda Film

Interview

High-Value Biomaterials en

High-Value Biomaterials

Research and Commercialization Center

Market Triumph Multidisciplinary Technology Medical Engineering Team

moreFrame en

HBRCC will assist researchers and industries to optimize formulas and mass production of powder/granule or liquid/gel biomaterials and derive high value biomedical implants. We also offer biomaterial rapid commercialization, a one-of-a-kind service.

Partnerships

Explore Mt3 Lab